The Discounted Cash Flow (DCF) valuation of Santen Pharmaceutical Co Ltd (4536.T) is 2,423.62 JPY. With the latest stock price at 1,644.50 JPY, the upside of Santen Pharmaceutical Co Ltd based on DCF is 47.4%.
Based on the latest price of 1,644.50 JPY and our DCF valuation, Santen Pharmaceutical Co Ltd (4536.T) is a buy. buying 4536.T stocks now will result in a potential gain of 47.4%.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 6.6% | 5.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 1,673.44 - 4,824.52 | 2,423.62 |
| Upside | 1.8% - 193.4% | 47.4% |